Ahead of GHS2025, we sat down with Biogen's Fraser Hall to discuss pharmaceutical innovations in healthspan, the potential of felzartamab in age-related conditions, and health equity in therapy distribution. https://longevity.technology/news/navigating-the-future-of-alzheimers-therapies/